What Is “Big Three Positive” Hepatitis B?

Hepatitis B is a well-known disease; however, it can significantly affect an individual’s normal work and daily life. What exactly is “Big Three-Positive” hepatitis B?

What Is “Big Three-Positive” Hepatitis B?

“Big Three-Positive” hepatitis B is a specific serological pattern of chronic hepatitis B infection, defined by positivity for three markers in the hepatitis B panel: hepatitis B surface antigen (HBsAg), hepatitis B e-antigen (HBeAg), and hepatitis B core antibody (anti-HBc). Following hepatitis B virus (HBV) infection—particularly during adolescence—the immune system may fail to recognize or effectively clear the virus.

However, a “Big Three-Positive” status alone should not be assumed to indicate severe disease. Further evaluation—including liver function tests, abdominal ultrasound (focusing on the liver and biliary system), and coagulation function assessment—is essential for comprehensive clinical assessment. If liver function remains normal and no hepatic damage is detected, the individual is typically classified as an asymptomatic HBV carrier and does not require immediate antiviral therapy; regular monitoring suffices. Conversely, if the disease progresses into an active phase of hepatitis B, prompt antiviral therapy, hepatoprotective treatment, and immunomodulation are warranted.

In cases where “Big Three-Positive” hepatitis B is relatively mild, conventional hepatoprotective therapy is recommended—primarily aimed at preventing further viral invasion and progression of liver injury. Since this condition is caused by chronic HBV infection, antiviral treatment is crucial to prevent progression to cirrhosis. During this process, hepatic fibrosis commonly develops; therefore, antifibrotic agents are advised. Immunomodulatory therapy may also be considered. We hope this information proves helpful to you.